Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP).
Rael CT, Lopez-Ríos J, McKenna SA, Das D, Dolezal C, Abascal E, Carballo-Diéguez A, Schnall R, Hope TJ, Bauermeister J, Bockting W. Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP). AIDS Behav. 2021 Dec; 25(12):4180-4192.